SILGARD 9

This brand name is authorized in Japan

Active ingredients

The drug SILGARD 9 contains a combination of these active pharmaceutical ingredients (APIs):

1 L1 protein of human papillomavirus type 6
UNII 61746O90DY - HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Read about L1 protein of human papillomavirus type 6
2 L1 protein of human papillomavirus type 11
UNII Z845VHQ61P - HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Read about L1 protein of human papillomavirus type 11
3 L1 protein of human papillomavirus type 16
UNII 7XB76X2V7T - HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN
Read about L1 protein of human papillomavirus type 16
4 L1 protein of human papillomavirus type 18
UNII J2D279PEM5 - HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
Read about L1 protein of human papillomavirus type 18
5 L1 protein of human papillomavirus type 31
UNII 53JIL371NS - HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN
Read about L1 protein of human papillomavirus type 31
6 L1 protein of human papillomavirus type 33
UNII 759RAC446C - HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN
Read about L1 protein of human papillomavirus type 33
7 L1 protein of human papillomavirus type 45
UNII 68S8VCN34F - HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN
Read about L1 protein of human papillomavirus type 45
8 L1 protein of human papillomavirus type 52
UNII 55644W68FD - HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN
Read about L1 protein of human papillomavirus type 52
9 L1 protein of human papillomavirus type 58
UNII 94Y15HP7LF - HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN
Read about L1 protein of human papillomavirus type 58

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BM03 J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BM Papillomavirus vaccines
Discover more medicines within J07BM03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: JP 医薬品医療機器総合機構 Identifier(s): 631341CG1023

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈